News Medical's "Thought Leaders" series is a selection of articles written by national and
international experts and trusted advisers in the life sciences industry. All the articles are
written by experts who have been invited as recognised leaders in their fields to provide
a "state of the art" contribution.
News-Medical speaks to Dr. Venita Decker, Dr. Joerg Koehler, and Dr. Andrea Kiehne about the latest challenges in narcotic analysis, and the methods being implemented to help tackle this global NPS issue.
In this interview, Ghaith Hamza from AstraZeneca talks to News-Medical Life Sciences about the basic principles of Affinity-Bead Assisted Mass Spectrometry (Affi-BAMS) and how Affi-BAMS can help target specific proteins for proteomic applications.
In this interview, Francesco Simone Ruggeri from the University of Cambridge talks to News-Medical Life Sciences about their research into biomolecules and the methods that are helping to achieve spectra at the single-molecule scale.
Breast cancer is the leading cause of cancer-related death among the female population globally, despite the ever-growing technology of early detection.
In this interview, Oscar Millet, group leader of the Precision Medicine and Metabolism group of the CIC bioGUNE, talked to News Medical about his research into the use of nuclear magnetic resonance spectroscopy (NMR) metabolomic analysis as a clinical screening tool. His team has used NMR to screen urine samples form new-borns for congenital metabolic disorders.
The last decade has seen a revolution in cancer immunotherapy. The demand from doctors, researchers, and pharmaceutical companies for more precise results with high sensitivity and high-quality testing is increasing immensely.
Mass spectrometry has always had a powerful synergy with computers. Computers have pushed mass spectrometry forward at key junctures in it’s history from data collection to instrument operation to data analysis.
Professor Deborah Goberdhan speaks to News-Medical about her team's latest research into cancer cells, and the mechanisms they use to communicate.
Professor Guillermo Montoya spoke to News-Medical on his research that involved visualizing the largest and most complex CRISPR system.
An interview with Amanda Hummon, discussing how mass spectrometry can be used to analyze the proteome and how this can help with the study of human disease.
An interview with Daniel Armstrong about the evolution of separation science and its recent and future developments.
An interview discussing the use of spherical nucleic acids (SNAs) and what they show about the importance of structure in pharmaceutical development.
An interview with Livia Eberlin, Assistant Professor at the University of Texas at Austin, discussing the development of mass-spectrometry based techniques for cancer diagnosis and improved clinical outcomes.
Marijuana-infused edibles or medibles have increased immensely over the last 10 years. With products such as brownies and gummy bears infused with marijuana, it is more important now than ever to test these cannabis-related products.
In this interview, Dr. Nancy Allbritton from The Allbritton Lab talks to News-Medical and Life Sciences about the revolutionary technology and techniques for the application of new technologies for oncology and stem cell research.
In this interview, Dr. Polinski and Dr. Atabakhsh discuss the importance of developing biomarkers for Parkinson’s and the partnership between MJFF and Abcam.
In this interview, Joshua Crossney talks to News-Medical Life Sciences about the recent advancements in the Cannabis industry and why quality anslyis and quality control are more important now than ever for cannabis medicinal products.
This interview provides insight into microfluidic systems and devices and the role they are playing in sweat analysis and neonatal care.
In this interview discover how combining Improved Ion Usage Efficiency with Data Independent Acquisition can help to Quantify Proteomes
Dr. Andrew Webb describes how his lab uses mass spectrometry-based techniques to understand the role of post-translational modifications in human disease.